Survivorship in a population based cohort of patients with Sjogren's syndrome, 1976-1992

Journal of Rheumatology

Volumn 26, Issue 6, 1999, Pages 1296-1300

  Martens, Peter B ^b   Pillemer, Stanley R ^b   Jacobsson, Lennert T H ^b   O'Fallon, W Michael ^b   Matteson, Eric L ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Epidemiology; Mortality; Sjogren's syndrome

Indexed keywords

ARTICLE; CAUSE OF DEATH; CLINICAL FEATURE; COMORBIDITY; FEMALE; HUMAN; INCIDENCE; KERATOCONJUNCTIVITIS SICCA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SJOEGREN SYNDROME; SURVIVAL RATE; UNITED STATES; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SJOGREN'S SYNDROME; SURVIVAL RATE;

EID: 0032995905     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. McCurley TL, Deaver Collins R, Ball E, Collins RD. Nodal and extranodal lymphoproliferative disorders in Sjögren's syndrome: a clinical and immunopathologic study. Human Pathol 1990; 21:482-92.
2. Talal N, Sokoloff L, Barth WF. Extrasalivary lymphoid abnormalities in Sjögren's syndrome (reticulum cell sarcoma, "pseudolymphoma," macroglobulinemia). Am J Med 1967; 43:50-65.
3. Santana V, Rose NR. Neoplastic lymphoproliferation in autoimmune disease: an updated review. Clin Immunol Immunopathol 1992;63:205-13.
4. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
5. Strimlan CV, Rosenow EC, Divertie MB, Harrison EG. Pulmonary manifestations of Sjögren's syndrome. Chest 1976;70:354-61.
6. Constantopoulos SH, Moutsopoulos HM. Respiratory involvement in patients with Sjögren's syndrome: is it a problem? Scand J Rheumatol 1986; Suppl 61:146-50.
7. Kelly CA, Foster H, Pal B, et al. Primary Sjögren's syndrome in North East England - a longitudinal study. Br J Rheumatol 1991;30:437-42.
8. Hunninghake GW, Fauci AS. Pulmonary involvement in collagen vascular diseases. Am Rev Respir Dis 1979;119:471-503.
9. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-74.
10. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am 1981;245:54-63.
11. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
13. Schroeder DJ, Offord KP. A SAS macro which utilizes local and reference population counts appropriate for incidence, prevalence, and mortality rate calculations in Rochester and Olmsted County, Minnesota. Technical Report Series No. 20, Section of Medical Research Statistics, Mayo Clinic, Rochester, Minnesota, August 1982.
14. Wolfe F, Mitchell DM, Sibley JT, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
15. Papathanasiou MP, Constantopoulos SH, Tsampoulas C, Drosos AA, Moutsopoulos HM. Reappraisal of respiratory abnormalities in primary and secondary Sjögren's syndrome. Chest 1986;90:370-4.
16. Anderson LG, Talal N. The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. Clin Exp Immunol 1972;10:199-221.
17. Kruize AA, Hene RJ, van der Heide A, et al. Long-term followup of patients with Sjögren's syndrome. Arthritis Rheum 1996; 39:297-303.
18. Pariente D, Anaya JM, Combe B, et al. Non-Hodgkin's lymphoma associated with primary Sjögren's syndrome. Eur J Med 1992;1:337-42.
19. Zufferey P, Meyer OC, Grossin M, Kahn MF. Primary Sjögren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS. Scand J Rheumatol 1995;24:342-5.
20. Malinow KL, Molina R, Gordon B, Selnes OA, Provost TT, Alexander EL. Neuropsychiatric dysfunction in primary Sjögren's syndrome. Ann Intern Med 1985;103:344-50.